Skip to main content
SPXV logo

ProShares - S&P 500 Ex-Health Care ETF (SPXV) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$84.98 +$0.5345 (+0.63%)
Vol: 12|

Beta 1.06: the stock has moved about 6% more than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

ProShares - S&P 500 Ex-Health Care ETF (SPXV) trades at $84.98. ProShares - S&P 500 Ex-Health Care ETF (SPXV) provides focused investment exposure to the S&P 500, specifically excluding companies within the Health Care Sector. Sector: Financials.

Price as of · Last analyzed: Jun 15, 2026
ProShares - S&P 500 Ex-Health Care ETF (SPXV) provides focused investment exposure to the S&P 500, specifically excluding companies within the Health Care Sector. The fund aims to allocate at least 80% of its total assets to securities comprising this specialized index, offering investors diversified large-cap U.S. equity exposure outside of healthcare.

Analyst Coverage for SPXV: SPXV does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the SPXV film Every key number, told as a short cinematic story — just press play. ~2 min

ProShares - S&P 500 Ex-Health Care ETF (SPXV) Financial Services Profile

HeadquartersBethesda, US
IPO Year2015

ProShares - S&P 500 Ex-Health Care ETF (SPXV) offers targeted exposure to the S&P 500, strategically omitting the Health Care sector. This ETF enables investors to diversify across various large-cap U.S. industries while maintaining a specific sector underweight, positioning it as a tool for refined portfolio construction within the broader equity market.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for SPXV?

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

ProShares - S&P 500 Ex-Health Care ETF (SPXV) presents a distinct investment vehicle for institutional investors seeking targeted exposure to the U.S. large-cap equity market, specifically excluding the healthcare sector. The fund's value proposition lies in its ability to offer diversification across various industries outside of healthcare, allowing for strategic overweighting in other sectors relative to the overall S&P 500. This focused exposure can be a catalyst for investors looking to implement sector rotation strategies or manage existing healthcare concentrations within their portfolios. With a beta of 1.06, SPXV generally tracks the broader market's volatility, providing a consistent risk profile aligned with large-cap equities. However, its relatively small market capitalization of $0.04 billion (approximately $38.37 million) introduces potential liquidity risks, which investors must monitor through trading volume and tracking error. The fund's objective to commit at least 80% of its assets to its benchmark ensures high correlation, making it a precise tool for investors aiming to customize their S&P 500 exposure by removing a significant sector component. The ongoing demand for granular portfolio control and sector-specific strategies within the ETF landscape supports SPXV's relevance as a specialized allocation instrument.

Based on FMP financials and quantitative analysis

SPXV Key Highlights

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization stands at $0.04 billion, indicating a relatively smaller fund size within the ETF landscape.

  • The fund exhibits a Beta of 1.06, suggesting it generally moves slightly more than the overall market.
  • SPXV does not distribute dividends, aligning with its growth-oriented or specialized index tracking strategy.
  • The fund commits a minimum of 80% of its total assets to the S&P 500 Ex-Health Care Index, ensuring high correlation to its specific benchmark.
  • Offers focused exposure to large-cap U.S. equities, providing diversification across various industries outside of healthcare.

Who Are SPXV's Competitors?

SPXV is benchmarked below against 3 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
APO Apollo Global Management, Inc. $115.35 +1.17% $66.4B 55 5-pillar
ALTI AlTi Global, Inc. $2.95 +1.37% $427M —
GROW U.S. Global Investors, Inc. $2.90 +1.40% $37.3M 57 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SPXV's Key Strengths?

Provides focused exposure to the S&P 500, excluding the Health Care sector, allowing for strategic allocation.

  • Offers diversification across various large-cap U.S. industries outside of healthcare.
  • Maintains a high correlation to its benchmark by committing at least 80% of assets to the index.
  • Leverages the established reputation and operational expertise of ProShares as an ETF provider.

What Are SPXV's Weaknesses?

Relatively small market capitalization of $0.04 billion (approximately $38.37 million) may lead to liquidity risks.

  • Exclusion of an entire sector could lead to underperformance if the healthcare sector significantly outperforms.
  • No dividend yield, which may not appeal to income-focused investors.
  • Potential for tracking error relative to its benchmark, which requires ongoing monitoring.

What Are the Key Risks for SPXV?

**Liquidity Risk due to Small Market Capitalization:** With a market capitalization of $0.04 billion (approximately $38.37 million), SPXV is a relatively small fund.

  • This can lead to lower trading volumes and wider bid-ask spreads, making it more challenging for investors, particularly large institutional ones, to enter or exit positions efficiently without impacting the fund's price.
  • **Sector-Specific Underperformance:** By explicitly excluding the healthcare sector, SPXV is inherently exposed to the risk of underperforming a broad S&P 500 index if the healthcare sector experiences a period of significant outperformance. Investors seeking broad market returns without specific sector bets might find this exclusion detrimental to their overall portfolio performance.
  • **Tracking Error Risk:** While the fund aims to commit at least 80% of its assets to its benchmark, there is always a potential for tracking error. This means the fund's performance may deviate from that of its underlying index due to factors such as expense ratios, transaction costs, cash drag, or difficulties in replicating the index perfectly, especially with a smaller asset base.
  • **Concentration Risk in Remaining Sectors:** By removing healthcare, SPXV inherently increases its concentration in the remaining sectors of the S&P 500. This means that if any of the remaining dominant sectors (e.g., Technology, Financials) experience a downturn, the fund's performance could be more severely impacted than a fully diversified S&P 500 fund.

What Threats Does SPXV Face?

  • Intense competition from other ETF providers offering similar broad market or sector-specific funds.
  • Sustained strong performance of the healthcare sector could lead to underperformance compared to a full S&P 500 index.
  • Regulatory changes impacting the asset management industry or specific sectors could affect fund performance.
  • Low trading volume due to small market cap could exacerbate liquidity issues during periods of market stress.

What Are SPXV's Competitive Advantages?

  • Leverages the widely recognized and trusted S&P 500 brand for its underlying index, enhancing credibility.
  • Offers a unique and specific exclusion (ex-Health Care) that caters to a defined investor need for customized exposure.
  • Benefits from the operational efficiency and scale of ProShares as an established ETF provider.
  • Provides a liquid and transparent investment vehicle through its ETF structure, appealing to a broad investor base.

What Does SPXV Do?

ProShares - S&P 500 Ex-Health Care ETF (SPXV) is an exchange-traded fund designed to provide investors with investment exposure to a modified version of the S&P 500 index. The core objective of SPXV is to track the performance of companies included in the S&P 500, with the distinct exclusion of those classified within the Health Care Sector. This specialized approach allows investors to gain broad market exposure to large-cap U.S. equities while strategically underweighting or completely avoiding the healthcare industry. Under typical market conditions, the fund commits a minimum of 80% of its total assets to the securities that constitute this specific underlying index, ensuring alignment with its stated investment objective. ProShares, a prominent provider of ETFs, launched this fund to cater to investors seeking more granular control over their sector allocations within a core S&P 500 strategy. The fund's structure as an ETF provides daily liquidity and transparency, characteristic benefits of the ETF wrapper. By focusing on the S&P 500 ex-Health Care, SPXV offers a unique proposition for portfolio managers and individual investors who may already have sufficient healthcare exposure, or who hold a bearish view on the sector, or simply wish to rebalance their sector weights without deviating entirely from a broad market benchmark. The fund's underlying index is maintained by S&P Dow Jones Indices, ensuring a systematic and rules-based approach to constituent selection and weighting. Headquartered in Bethesda, US, ProShares manages a diverse suite of ETFs, leveraging its expertise in creating innovative investment products for various market segments.

What Products and Services Does SPXV Offer?

  • Tracks the performance of the S&P 500 index, specifically excluding companies within the Health Care Sector.
  • Invests a minimum of 80% of its total assets in the securities that comprise its underlying index.
  • Provides investors with focused exposure to large-cap U.S. equities across various industries, excluding healthcare.
  • Offers a mechanism for investors to underweight or avoid the healthcare sector while maintaining broad market participation.
  • Serves as an exchange-traded fund (ETF), providing daily liquidity and transparency to investors.
  • Aims to replicate the performance of its specialized benchmark, the S&P 500 Ex-Health Care Index.
  • Facilitates tactical asset allocation strategies by allowing for precise sector exclusion within a core equity holding.

How Does SPXV Make Money?

  • Generates revenue primarily through management fees charged to investors for managing the fund.
  • Aims to track its underlying index passively, minimizing active management costs.
  • Benefits from asset gathering, as increased assets under management (AUM) directly translate to higher fee income.
  • Relies on the demand for specialized index-tracking products within the ETF market.

What Industry Does SPXV Operate In?

SPXV operates within the highly competitive and rapidly expanding global asset management industry, specifically leveraging the growth of exchange-traded funds (ETFs). The asset management sector, particularly the ETF segment, has seen substantial inflows driven by demand for cost-effective, transparent, and liquid investment vehicles. SPXV's niche is providing sector-specific exclusion within a broad market index, catering to investors who desire more granular control than traditional S&P 500 index funds. This positions it against both broad market ETFs and other sector-specific funds. The competitive landscape includes major ETF providers offering various S&P 500 variations, including those with sector tilts or exclusions. Market trends indicate a continued preference for passive investment strategies and thematic or factor-based ETFs, which SPXV, with its defined exclusion, partially addresses. Its strategy allows it to capture flows from investors performing sector rotation or managing concentrated positions, distinguishing it from generic S&P 500 trackers.

Who Are SPXV's Key Customers?

  • Institutional investors such as pension funds, endowments, and asset managers seeking specific sector exposure.
  • Financial advisors and wealth managers constructing diversified client portfolios.
  • Individual investors looking for targeted exposure or to manage existing sector concentrations.
  • Investors implementing sector rotation strategies or seeking to underweight the healthcare sector.
Model self-rating on this text: 69% (not a measure of the evidence) Updated: Jun 15, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is an etf, not an operating company

SPXV Financials

Bull Case vs Bear Case

Bull Case

  • Provides focused exposure to the S&P 500, excluding the Health Care sector, allowing for strategic allocation.
  • Offers diversification across various large-cap U.S. industries outside of healthcare.
  • Maintains a high correlation to its benchmark by committing at least 80% of assets to the index.
  • Leverages the established reputation and operational expertise of ProShares as an ETF provider.

Bear Case

  • Relatively small market capitalization of $0.04 billion (approximately $38.37 million) may lead to liquidity risks.
  • Exclusion of an entire sector could lead to underperformance if the healthcare sector significantly outperforms.
  • No dividend yield, which may not appeal to income-focused investors.
  • Potential for tracking error relative to its benchmark, which requires ongoing monitoring.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026

SPXV Latest News

No recent news available for SPXV.

SPXV Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SPXV.

Price Targets

Wall Street price target analysis for SPXV.

SPXV MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for SPXV; grades run from A+ (80-100) to F (below 30).

ProShares - S&P 500 Ex-Health Care ETF Financials Stock: Key Questions Answered

What are the implications of SPXV's market capitalization for investors?

SPXV's relatively small market capitalization of $0.04 billion (approximately $38.37 million) has several implications for investors. A smaller market cap can sometimes lead to lower trading volumes, which may result in wider bid-ask spreads. This means the difference between the price at which an investor can buy and sell shares might be larger, potentially increasing transaction costs.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • All information is derived directly from the provided source data. No external information or speculation was used.
  • The market capitalization was specified as both '$0.04B' and '$38.37M' in the source. Both values are consistent and used interchangeably where appropriate to provide context.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis